Literature DB >> 30883696

A Review of the Regulatory Framework for Initiation and Acceleration of Patient Access to Innovative Medical Products in Japan.

Shunsuke Matsushita1, Keisuke Tachibana1, Kiyohito Nakai2, Shoji Sanada3, Masuo Kondoh1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30883696     DOI: 10.1002/cpt.1383

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  2 in total

Review 1.  Overview of the Premarketing and Postmarketing Requirements for Drugs Granted Japanese Conditional Marketing Approval.

Authors:  Shunsuke Matsushita; Keisuke Tachibana; Tetsuya Kusakabe; Ryuichi Hirayama; Yasuo Tsutsumi; Masuo Kondoh
Journal:  Clin Transl Sci       Date:  2021-04-03       Impact factor: 4.689

Review 2.  A Concept for a Japanese Regulatory Framework for Emerging Medical Devices with Frequently Modified Behavior.

Authors:  Nagomi Ota; Keisuke Tachibana; Tetsuya Kusakabe; Shoji Sanada; Masuo Kondoh
Journal:  Clin Transl Sci       Date:  2020-04-03       Impact factor: 4.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.